Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trials In Progress
632 Clinical update from a phase 1, first-in-human, open-label single agent study of SUPLEXA therapeutic cells in patients with metastatic solid tumours and haematologic malignancies
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 632 Clinical update from a phase 1, first-in-human, open-label single agent study of SUPLEXA therapeutic cells in patients with metastatic solid tumours and haematologic malignancies